Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Intuitive Surgical (ISRG) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical Instruments & SuppliesISRG

Closing price · Nov 19, 2026 $409.00 -2.8% on the day · -27.6% over 12 months 52-week range $332.02 – $592.85
Get ISRG alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling9last 12 months
Reported sales$65.4M99 of 99 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Jan 17, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Mark Brosius, Evp & Chief Mfg And Supply Cha sold 46 shares at $444.38 ($20K).

Trade date
Nov 16, 2026
Disclosed to the SEC
Nov 18, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All ISRG insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

ISRG insider transactions (Form 4)

Open-market purchases and sales. 170 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 18SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 46411 held (−10%) $444.38 $20K -8.0% —
Nov 18SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 46365 held (−11%) $437.33 $20K -6.5% —
Nov 18SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 46319 held (−13%) $430.63 $20K -5.0% —
Nov 12SEC Gary LoebGeneral Counsel Sell Plan 4006,236 held (−6%) $458.15 $183K -10.7% —
Nov 5SEC Gary S. GuthartDirector Sell Plan 10,0001,194,530 held (−1%) $457.34 $4.6M -10.6% —
Nov 5SEC Craig H. BarrattDirector Sell Plan 1,150 $460.00 $529K -11.1% —
Nov 2SEC Fredrik WidmanVp Corporate Controller Sell Plan 5,4481,026 held (−84%) $436.06 $2.4M -6.2% —
Nov 2SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 63457 held (−12%) $453.60 $29K -9.8% —
Nov 2SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 61520 held (−10%) $447.85 $27K -8.7% —
Oct 28SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 61703 held (−8%) $451.75 $28K -9.5% —
Oct 28SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 61642 held (−9%) $451.63 $28K -9.4% —
Oct 28SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 61581 held (−10%) $441.60 $27K -7.4% —
Oct 26SEC Gary S. GuthartDirector Sell Plan 20,0951,204,530 held (−2%) $451.61 $9.1M -9.4% —
Oct 26SEC Fredrik WidmanVp Corporate Controller Sell Plan 4,0471,026 held (−80%) $453.21 $1.8M -9.8% —
Oct 26SEC Craig H. BarrattDirector Sell Plan 1,150 $443.80 $510K -7.8% —
Oct 26SEC Patricia L. WadorsSvp Chief Human Resources Offi Sell Plan 1,078 $443.80 $478K -7.8% —
Sep 16SEC Fredrik WidmanVp Corporate Controller Sell Plan 5461,026 held (−35%) $374.44 $204K +9.2% —
Sep 16SEC Fredrik WidmanVp Corporate Controller Sell Plan 5431,026 held (−35%) $374.44 $203K +9.2% —
Sep 11SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 25764 held (−3%) $365.79 $9K +11.8% —
Sep 11SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 23789 held (−3%) $347.66 $8K +17.6% —
Sep 9SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 46835 held (−5%) $361.23 $17K +13.2% —
Sep 9SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 23812 held (−3%) $350.20 $8K +16.8% —
Aug 21SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 77958 held (−7%) $396.37 $31K +3.2% —
Aug 21SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 77881 held (−8%) $375.57 $29K +8.9% —
Aug 19SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 771,035 held (−7%) $394.26 $30K +3.7% —
Aug 19SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 771,112 held (−6%) $394.00 $30K +3.8% —
Aug 19SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 771,189 held (−6%) $390.67 $30K +4.7% —
Aug 12SEC Gary S. GuthartDirector Sell Plan 10,0001,245,679 held (−1%) $400.00 $4.0M +2.2% —
Aug 11SEC Amy L. LaddDirector Sell Plan 400251 held (−61%) $379.00 $152K +7.9% —
Aug 11SEC Amy L. LaddDirector Sell Plan 72179 held (−29%) $393.10 $28K +4.0% —
Aug 10SEC Gary LoebGeneral Counsel Sell Plan 4005,320 held (−7%) $379.00 $152K +7.9% —
Jul 31SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 281,266 held (−2%) $351.00 $10K +16.5% —
Jul 31SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 281,294 held (−2%) $346.83 $10K +17.9% —
Jul 29SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 281,350 held (−2%) $365.58 $10K +11.9% —
Jul 29SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 281,322 held (−2%) $360.21 $10K +13.5% —
Jul 29SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 281,378 held (−2%) $344.00 $10K +18.9% —
Jun 12SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 251,406 held (−2%) $414.13 $10K -1.2% —
Jun 12SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 231,431 held (−2%) $412.16 $9K -0.8% —
Jun 10SEC Gary LoebGeneral Counsel Sell Plan 4005,720 held (−7%) $424.14 $170K -3.6% —
Jun 10SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 231,454 held (−2%) $424.14 $10K -3.6% —
Jun 10SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 231,477 held (−2%) $421.13 $10K -2.9% —
Jun 10SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 231,500 held (−2%) $420.12 $10K -2.6% —
Jun 2SEC Iman JeddiSvp & Gm Da Vinci Platforms & Sell Plan 5,6256,463 held (−47%) $420.55 $2.4M -2.7% —
May 22SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 181,541 held (−1%) $446.04 $8K -8.3% —
May 22SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 181,523 held (−1%) $439.80 $8K -7.0% —
May 20SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 181,577 held (−1%) $440.70 $8K -7.2% —
May 20SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 181,559 held (−1%) $440.38 $8K -7.1% —
May 20SEC Mark BrosiusEvp & Chief Mfg And Supply Cha Sell Plan 181,595 held (−1%) $422.47 $8K -3.2% —
May 11SEC Gary LoebGeneral Counsel Sell Plan 4006,120 held (−6%) $446.95 $179K -8.5% —
Apr 29SEC Amy L. LaddDirector Sell Plan 500239 held (−68%) $473.46 $237K -13.6% —
Apr 29SEC Amy L. LaddDirector Sell Plan 119120 held (−50%) $463.50 $55K -11.8% —
Mar 11SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 105 $493.95 $52K -17.2% —
Mar 10SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 6482,258 held (−22%) $490.19 $318K -16.6% —
Mar 10SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 6451,613 held (−29%) $485.01 $313K -15.7% —
Mar 5SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 2,3623,554 held (−40%) $498.68 $1.2M -18.0% —
Mar 5SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 6482,906 held (−18%) $495.20 $321K -17.4% —
Mar 5SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 6485,916 held (−10%) $488.10 $316K -16.2% —
Mar 3SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 4,728409 held (−92%) $487.18 $2.3M -16.0% —
Mar 3SEC Fredrik WidmanVp Corporate Controller Sell Plan 249909 held (−22%) $499.71 $124K -18.2% —
Mar 3SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 1255,137 held (−2%) $492.59 $62K -17.0% —
Mar 3SEC Fredrik WidmanVp Corporate Controller Sell Plan 1181,026 held (−10%) $487.18 $57K -16.0% —
Mar 2SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 2,345409 held (−85%) $499.71 $1.2M -18.2% —
Feb 27SEC Patricia L. WadorsSvp Chief Human Resources Offi Sell Plan 220 $499.71 $110K -18.2% —
Feb 11SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 421409 held (−51%) $494.96 $208K -17.4% —
Feb 11SEC Fredrik WidmanVp Corporate Controller Sell Plan 133660 held (−17%) $494.96 $66K -17.4% —
Feb 11SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 105830 held (−11%) $494.65 $52K -17.3% —
Jan 30SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 126 $520.02 $66K -21.3% —
Jan 28SEC Gary S. GuthartDirector Sell Plan 24,5003,694 held (−87%) $530.10 $13.0M -22.8% —
Jan 28SEC Gary S. GuthartDirector Sell Plan 1,40015,720 held (−8%) $531.53 $744K -23.1% —
Jan 28SEC Gary S. GuthartDirector Sell Plan 1,40015,720 held (−8%) $531.52 $744K -23.1% —
Jan 28SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 125 $532.61 $67K -23.2% —
Jan 28SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 105 $532.61 $56K -23.2% —
Dec 17SEC Mark BrosiusSee Remarks Sell Plan 464131 held (−78%) $548.49 $254K -25.4% —
Dec 17SEC Mark BrosiusSee Remarks Sell Plan 312595 held (−34%) $547.36 $171K -25.3% —
Dec 15SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 4,500907 held (−83%) $547.36 $2.5M -25.3% —
Dec 15SEC Mark BrosiusSvp & Chief Mfg And Supply Cha Sell Plan 464443 held (−51%) $548.49 $254K -25.4% —
Dec 10SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 104 $559.90 $58K -27.0% —
Dec 2SEC Gary S. GuthartChair Sell Plan 22,8062,694 held (−89%) $570.89 $13.0M -28.4% —
Dec 2SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 125 $568.99 $71K -28.1% —
Nov 13SEC Henry L. CharltonEvp & Chief Commercial And Mkt Sell Plan 4,7313,056 held (−61%) $580.00 $2.7M -29.5% —
Nov 13SEC Henry L. CharltonEvp & Chief Commercial And Mkt Sell Plan 2,9017,787 held (−27%) $580.00 $1.7M -29.5% —
Nov 13SEC Henry L. CharltonEvp & Chief Commercial And Mkt Sell Plan 2,8987,787 held (−27%) $580.00 $1.7M -29.5% —
Nov 13SEC Henry L. CharltonEvp & Chief Commercial And Mkt Sell Plan 2,5657,787 held (−25%) $580.00 $1.5M -29.5% —
Nov 13SEC Craig H. BarrattDirector Sell Plan 750 $580.00 $435K -29.5% —
Nov 13SEC Henry L. CharltonEvp & Chief Commercial And Mkt Sell Plan 6367,787 held (−8%) $580.00 $369K -29.5% —
Nov 12SEC Brian Edward MillerEvp & Chief Digital Officer Sell Plan 2,2025,758 held (−28%) $575.00 $1.3M -28.9% —
Nov 12SEC Brian Edward MillerEvp & Chief Digital Officer Sell Plan 1,2985,758 held (−18%) $575.00 $746K -28.9% —
Nov 12SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 105 $560.00 $59K -27.0% —
Nov 6SEC Fredrik WidmanVp Corporate Controller Sell Plan 1,908473 held (−80%) $550.00 $1.0M -25.6% —
Nov 6SEC Fredrik WidmanVp Corporate Controller Sell Plan 159473 held (−25%) $550.00 $87K -25.6% —
Oct 29SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 5,030353 held (−93%) $548.43 $2.8M -25.4% —
Oct 29SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 1,379353 held (−80%) $548.43 $756K -25.4% —
Oct 29SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 1,153353 held (−77%) $548.43 $632K -25.4% —
Oct 29SEC Myriam CuretEvp & Chief Medical Officer Sell Plan 125 $543.00 $68K -24.7% —
Oct 27SEC Gary S. GuthartChair Sell Plan 28,80027,027 held (−52%) $547.56 $15.8M -25.3% —
Oct 27SEC David J. RosaCEO Sell Plan 24,500234,256 held (−9%) $547.55 $13.4M -25.3% —
Oct 27SEC Craig H. BarrattDirector Sell Plan 2,193 $548.01 $1.2M -25.4% —
Oct 27SEC Gary S. GuthartChair Sell Plan 1,40017,120 held (−8%) $546.35 $765K -25.1% —
Oct 27SEC Gary S. GuthartChair Sell Plan 1,40017,120 held (−8%) $546.18 $765K -25.1% —
Historical context

Similar past setups: not applicable. ISRG has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with ISRG in the Research Lab

ISRG has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

ISRG closeInsider buyInsider sale
300400500600DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-01-14EEarnings release filed 2026-01-22EEarnings release filed 2026-04-21EEarnings release filed 2026-07-16EEarnings release filed 2026-10-20Sold $7,604 on 2026-05-18 · Mark BrosiusSold $7,916 on 2026-05-22 · Mark BrosiusSold $7,927 on 2026-05-20 · Mark BrosiusSold $7,933 on 2026-05-19 · Mark BrosiusSold $7,996 on 2026-09-10 · Mark BrosiusSold $8,029 on 2026-05-21 · Mark BrosiusSold $8,055 on 2026-09-09 · Mark BrosiusSold $9,145 on 2026-09-11 · Mark BrosiusSold $9,480 on 2026-06-11 · Mark BrosiusSold $9,632 on 2026-07-27 · Mark BrosiusSold $9,663 on 2026-06-08 · Mark BrosiusSold $9,686 on 2026-06-09 · Mark BrosiusSold $9,711 on 2026-07-30 · Mark BrosiusSold $9,828 on 2026-07-31 · Mark BrosiusSold $10,086 on 2026-07-29 · Mark BrosiusSold $10,236 on 2026-07-28 · Mark BrosiusSold $10,353 on 2026-06-12 · Mark BrosiusSold $16,617 on 2026-09-08 · Mark BrosiusSold $19,809 on 2026-11-18 · Mark BrosiusSold $20,117 on 2026-11-17 · Mark BrosiusSold $20,441 on 2026-11-16 · Mark BrosiusSold $26,938 on 2026-10-28 · Mark BrosiusSold $27,319 on 2026-10-29 · Mark BrosiusSold $27,549 on 2026-10-27 · Mark BrosiusSold $27,557 on 2026-10-26 · Mark BrosiusSold $28,919 on 2026-08-21 · Mark BrosiusSold $30,082 on 2026-08-17 · Mark BrosiusSold $30,338 on 2026-08-18 · Mark BrosiusSold $30,358 on 2026-08-19 · Mark BrosiusSold $30,520 on 2026-08-20 · Mark BrosiusSold $51,865 on 2026-03-10 · Myriam CuretSold $51,938 on 2026-02-10 · Myriam CuretSold $55,156 on 2026-04-29 · Amy L. LaddSold $58,230 on 2025-12-10 · Myriam CuretSold $61,574 on 2026-03-02 · Myriam CuretSold $65,523 on 2026-01-29 · Myriam CuretSold $178,780 on 2026-05-11 · Gary LoebSold $179,411 on 2026-06-10 · Gary Loeb, Mark BrosiusSold $183,260 on 2026-11-10 · Gary LoebSold $236,730 on 2026-04-28 · Amy L. LaddSold $274,208 on 2026-02-11 · Fredrik Widman, Myriam CuretSold $303,200 on 2026-08-10 · Amy L. Ladd, Gary LoebSold $312,831 on 2026-03-09 · Mark BrosiusSold $317,643 on 2026-03-06 · Mark BrosiusSold $320,890 on 2026-03-05 · Mark BrosiusSold $407,765 on 2026-09-15 · Fredrik WidmanSold $508,999 on 2025-12-15 · Mark BrosiusSold $1,177,883 on 2026-03-04 · Mark BrosiusSold $1,406,184 on 2026-02-27 · Fredrik Widman, Myriam Curet, Patricia L. WadorsSold $2,365,594 on 2026-06-01 · Iman JeddiSold $2,404,205 on 2026-10-30 · Fredrik Widman, Mark BrosiusSold $2,633,896 on 2025-12-12 · Mark BrosiusSold $2,677,163 on 2026-03-03 · Fredrik Widman, Mark Brosius, Myriam CuretSold $4,028,303 on 2026-08-11 · Amy L. Ladd, Gary S. GuthartSold $5,102,373 on 2026-11-04 · Craig H. Barratt, Gary S. GuthartSold $11,898,048 on 2026-10-23 · Craig H. Barratt, Fredrik Widman, Gary S. Guthart, Patricia L. WadorsSold $13,090,846 on 2025-12-01 · Gary S. Guthart, Myriam CuretSold $14,598,173 on 2026-01-27 · Gary S. Guthart, Myriam Curet
Bought, 12 months$0
Sold, 12 months$65.4M
Insiders buying0
Insiders selling9

Intuitive Surgical insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 9 sold $65.4M of ISRG stock on the open market; P/E 53.0 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

ISRG insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $64.0M sold (27 trades)Q4 2025Q1 2026: $21.3M sold (21 trades)Q1 2026Q2 2026: $3.1M sold (15 trades)Q2 2026Q3 2026: $5.0M sold (20 trades)Q3 2026Q4 2026: $19.8M sold (16 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$19.8M16
Q3 2026—0$5.0M20
Q2 2026—0$3.1M15
Q1 2026—0$21.3M21
Q4 2025—0$64.0M27

Valuation, profit and volume

P/E (trailing)53.0Sector median 25.0
Market value$151.81BMedical Instruments & Supplies
Profit margin25.5%Revenue growth +21.7%
Volume vs. 50-day0.7×Last 5 sessions

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Intuitive Surgical insiders reported open-market purchases totaling $0, while 9 insiders reported sales totaling $65.4M. 99 of 99 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

ISRG earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Oct 20, 2026 +10.5% None -1.2%S&P +0.9% pending
Jul 16, 2026 -2.2% None -11.2%S&P -1.5% +14.2%
Apr 21, 2026 +3.0% None +3.9%S&P +0.4% -9.4%
Jan 22, 2026 -11.7% None +0.1%S&P +0.6% -3.8%
Jan 14, 2026 -2.4% Sold $509K -3.6%S&P -0.2% -10.3%
Oct 21, 2025 +1.4% None +15.0%S&P -0.5% +6.6%
Jul 22, 2025 -5.2% None -2.7%S&P +0.9% -5.1%
Apr 22, 2025 +3.7% None +4.2%S&P +4.2% +10.6%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

ISRG short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 61% of volume sold short2026-08-27: 65% of volume sold short2026-08-28: 54% of volume sold short2026-08-31: 47% of volume sold short2026-09-01: 42% of volume sold short2026-09-02: 46% of volume sold short2026-09-03: 43% of volume sold short2026-09-04: 45% of volume sold short2026-09-08: 48% of volume sold short2026-09-09: 55% of volume sold short2026-09-10: 65% of volume sold short2026-09-11: 65% of volume sold short2026-09-14: 63% of volume sold short2026-09-15: 54% of volume sold short2026-09-16: 63% of volume sold short2026-09-17: 62% of volume sold short2026-09-18: 61% of volume sold short2026-09-21: 72% of volume sold short2026-09-22: 51% of volume sold short2026-09-23: 51% of volume sold short2026-09-24: 49% of volume sold short2026-09-25: 58% of volume sold short2026-09-28: 64% of volume sold short2026-09-29: 45% of volume sold short2026-09-30: 44% of volume sold short2026-10-01: 43% of volume sold short2026-10-02: 42% of volume sold short2026-10-05: 58% of volume sold short2026-10-06: 57% of volume sold short2026-10-07: 60% of volume sold short2026-10-08: 59% of volume sold short2026-10-09: 59% of volume sold short2026-10-12: 51% of volume sold short2026-10-13: 43% of volume sold short2026-10-14: 44% of volume sold short2026-10-15: 43% of volume sold short2026-10-16: 66% of volume sold short2026-10-19: 66% of volume sold short2026-10-20: 61% of volume sold short2026-10-21: 62% of volume sold short2026-10-22: 56% of volume sold short2026-10-23: 68% of volume sold short2026-10-26: 28% of volume sold short2026-10-27: 48% of volume sold short2026-10-28: 46% of volume sold short2026-10-29: 44% of volume sold short2026-10-30: 45% of volume sold short2026-11-02: 29% of volume sold short2026-11-03: 37% of volume sold short2026-11-04: 58% of volume sold short2026-11-05: 51% of volume sold short2026-11-06: 45% of volume sold short2026-11-09: 48% of volume sold short2026-11-10: 40% of volume sold short2026-11-11: 30% of volume sold short2026-11-12: 32% of volume sold short2026-11-13: 37% of volume sold short2026-11-16: 44% of volume sold short2026-11-17: 31% of volume sold short2026-11-18: 44% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 44%20-day average: 44%Prior 2 months: 56%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded ISRG

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 -9.6%
Markwayne MullinSenate Bought $15,001 - $50,000 Dec 29, 2025Jan 16, 2026 -28.9%
Markwayne MullinSenate Bought $50,001 - $100,000 Sep 24, 2025Oct 1, 2025 -7.9%

Insiders at Intuitive Surgical

InsiderBoughtSoldLast filingPast buys beat S&PScore
Gary S. GuthartDirector — $62.4M Nov 5, 2026 — —
David J. RosaCEO — $13.4M Jul 13, 2026 — —
Myriam CuretEvp & Chief Medical Officer — $8.4M Mar 11, 2026 — —
Henry L. CharltonEvp & Chief Commercial And Mkt — $8.0M Mar 2, 2026 — —
Mark BrosiusEvp & Chief Mfg And Supply Cha — $6.1M Nov 18, 2026 — —
Fredrik WidmanVp Corporate Controller — $6.0M Nov 2, 2026 — —
Craig H. BarrattDirector — $2.7M Nov 5, 2026 — —
Iman JeddiSvp & Gm Da Vinci Platforms & — $2.4M Jun 2, 2026 — —
Brian Edward MillerEvp & Chief Digital Officer — $2.0M Nov 12, 2025 — —
Gary LoebGeneral Counsel — $683K Nov 12, 2026 — —
Patricia L. WadorsSvp Chief Human Resources Offi — $588K Oct 26, 2026 — —
Amy L. LaddDirector — $472K Aug 11, 2026 — —
Jami K. NachtsheimDirector — — Apr 30, 2026 1 of 1 —
Lewis ChewDirector — — Apr 30, 2026 — —
Joseph C. BeeryDirector — — Apr 30, 2026 — —
Amal M. JohnsonDirector — — Apr 30, 2026 1 of 1 —
Keith R. LeonardDirector — — Apr 30, 2026 — —
Sreelakshmi KolliDirector — — Apr 30, 2026 — —
Monica P. ReedDirector — — Apr 30, 2026 — —
Jamie SamathCFO — — Mar 2, 2026 — —

Board links: companies that share insiders with ISRG

Directors and executives who filed Form 4s for ISRG and another company in the last 12 months.

See the map →
  • ANETArista Networks Lewis Chew Director here · Director at ANET · latest filing Nov 17, 2026
  • ARQTArcutis Biotherapeutics Keith R. Leonard Director here · Director at ARQT · latest filing Apr 30, 2026
  • CDNSCadence Design Systems Lewis Chew Director here · Director at CDNS · latest filing Nov 12, 2026
  • ESSEssex Property Trust Amal M. Johnson Director here · Director at ESS · latest filing May 14, 2026
  • INSPInspire Medical Systems Myriam Curet Evp & Chief Medical Officer here · Director at INSP · latest filing Mar 11, 2026
  • INTCIntel Craig H. Barratt Director here · Director at INTC · latest filing Nov 5, 2026
  • KLACKLA Jamie Samath CFO here · Director at KLAC · latest filing Nov 5, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

ISRG stock: common questions

Are Intuitive Surgical insiders buying ISRG stock?

No. No Intuitive Surgical insider reported an open-market purchase of ISRG in the past 12 months.

Are Intuitive Surgical insiders selling ISRG stock?

9 insiders reported sales worth $65.4M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ISRG's P/E ratio?

ISRG trades at about 53.0 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is ISRG's 52-week range?

Over the past year ISRG has traded between $332.02 and $592.85. It last closed at $409.00 on Nov 19, 2026.